AD Blood Test Helps PCPs Rival Specialists’ Dx Accuracy

A groundbreaking blood test is now enabling primary care physicians to diagnose Alzheimer's disease with precision comparable to specialists, potentially reshaping how the condition is managed. This advancement means patients might see their PCP first, cutting down on the need for specialist visits and reducing overall healthcare costs. The test's ability to influence referral patterns, additional testing, and treatment decisions highlights its potential to make Alzheimer’s diagnosis more accessible and timely, ultimately improving patient outcomes.